Identification of kukoamine a as an anti-osteoporosis drug target using network pharmacology and experiment verification
Liying Luo(Tongren Hospital), Yanyun Jiang(Shanghai Jiao Tong University), Zhiyuan Guan(Tongji University), Zhiqiang Guan(Xuzhou Medical College), Xiao Jin(Xuzhou Medical College)
Cited by 16
Related Papers
The gut microbiota metabolite capsiate regulate SLC2A1 expression by targeting HIF‐1α to inhibit knee osteoarthritis‐induced ferroptosis
|Aging Cell|2023|116
A low-power Si:HfO2 ferroelectric tunnel memristor for spiking neural networks
|Nano Energy|2022|97
Estrogen deficiency induces bone loss through the gut microbiota
|Pharmacological Research|2023|85
Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice
|Clinical Science|2020|81
The Role of Depletion of Gut Microbiota in Osteoporosis and Osteoarthritis: A Narrative Review
|Frontiers in Endocrinology|2022|41